Content
Search
Navigation
Sitemap
About us
Pipeline & science
Overview
Obesity
Type 2 Diabetes Mellitus (T2DM)
Acute Ischemic Stroke (AIS)
Our expertise
Overview
Our strategic partners
Global opportunities
Join us
Press releases
Contact
简体中文
Search
简体中文
Navigation
Press releases
03 Jan 2024
JIXING Announces TFDA Acceptance of New Drug Application for Varenicline Solution Nasal Spray for the Taiwan Region
Read article
30 Dec 2023
JIXING Announces Positive Results From The China Cohort Of SEQUOIA-HCM, The Pivotal Phase 3 Clinical Trial Of Aficamten In Patients With Obstructive Hypertrophic Cardiomyopathy
Read article
27 Dec 2023
Cytokinetics Announces Positive Results From SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
Read article
13 Dec 2023
JIXING’s Milestone! The University of Hong Kong - Shenzhen Hospital issued the first prescription for Varenicline Solution Nasal Spray
Read article
14 Nov 2023
Milestone Pharmaceuticals Presents Positive Results from ReVeRA Phase 2 Study of Etripamil in AFib-RVR at the American Heart Association Scientific Sessions 2023
Read article
06 Nov 2023
JIXING and WuXi STA Announce Strategic Partnership Agreement
Read article
Load more
